MORGAN STANLEY

Holdings History for Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

Symbol: TRDA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$2,675,384	260,251	-86,505	-25%	$10.28	Q4 2025
30 Sep 2025	0%	+0%	$2,011,185	346,756	+183,659	+113%	$5.80	Q3 2025
30 Jun 2025	0%	+0%	$1,096,012	163,097	+89,436	+121%	$6.72	Q2 2025
31 Mar 2025	0%	-0%	$665,895	73,661	-8,212		$9.04	Q1 2025
31 Dec 2024	0%	-0%	$1,415,584	81,873	-11,393		$17.29	Q4 2024
30 Sep 2024	0%	+0%	$1,490,392	93,266	+44,215		$15.98	Q3 2024
30 Jun 2024	0%	-0%	$698,978	49,051	-58,511		$14.25	Q2 2024
31 Mar 2024	0%	+0%	$1,524,153	107,562	+58,258	+118%	$14.17	Q1 2024
31 Dec 2023	0%	+0%	$743,997	49,304	+28,358	+135%	$15.09	Q4 2023
30 Sep 2023	0%	-0%	$330,947	20,946	-8,957	-30%	$15.80	Q3 2023
30 Jun 2023	0%	-0%	$452,730	29,903	-11,865	-28%	$15.14	Q2 2023
31 Mar 2023	0%	+0%	$605,637	41,768	+16,882	+68%	$14.50	Q1 2023
31 Dec 2022	0%	+0%	$336,460	24,886	+14,356	+136%	$13.52	Q4 2022
30 Sep 2022	0%	-0%	$166,000	10,530	-10,546	-50%	$15.76	Q3 2022
30 Jun 2022		0%	$1,000	109	0		$9.17 ^*	Q2 2022
30 Jun 2022	0%	+0%	$257,000	21,076	+12,795	+155%	$12.19	Q2 2022
31 Mar 2022	0%	+0%	$77,000	8,281	+4,119	+99%	$9.30	Q1 2022
31 Mar 2022		0%	$1,000	80	0		$12.50 ^*	Q1 2022
31 Dec 2021	0%	+0%	$71,000	4,162	+4,162	NEW	$17.06	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.